Factor XIII substrates fibronectin fibrinogen plasma urine patients nephrosis Plasma urine concentrations factor XIII circulating substrates fibronectin fibrinogen group patients nephrotic syndrome results group normal volunteers group patients end-stage renal disease ESRD mild significant reduction plasma level abnormal urinary excretion alpha nephrotic group Plasma concentrations factor XIII fibronectin fibrinogen patients nephrosis contrast patients ESRD significant difference plasma concentrations factor XIII fibronectin modest elevation fibrinogen normal controls significant correlation serum creatinine concentration plasma levels factor XIII circulating substrates nephrotic group measurable quantities factor XIII small quantities fibronectin urine patients nephrosis Elevation plasma factor XIII fibronectin fibrinogen concentrations nephrotic group result combination increased synthesis intravascular distribution macromolecular proteins face negligible urinary losses presence observed abnormalities nephrotic group absence non-nephrotic ESRD group renal failure cause abnormalities clinical significance abnormalities uncertain thrombophilic diathesis platelet hyperaggregability nephrotic syndrome 